B&B Tools AB

SWF:NOVN ISIN:CH0012005267

Mit einem Umsatz von rund 2,8 Milliarden Euro im Jahr 2007 und einem Marktanteil von elf Prozent ist Novartis die umsatzstärkste Pharmaunternehmensgruppe im deutschen Gesundheitsmarkt. 
 
  

Sprache wählen

News

Novartis International AG (VTX:NOVN) Femara® First Aromatase Inhibitor To Indicate Survival Benefit Versus Tamoxifen When Taken For Five Years After Breast Cancer Surgery

🕔12/12/2008 2:47:00 AM 1785

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Exjade® Benefits Chronically Transfused Patients By Significantly Reducing Toxic Iron That Can Damage Key Organs, According To Landmark Trial

🕔12/9/2008 10:33:00 AM 2359

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Tasigna® Demonstrates Rapid Response As Initial Therapy In Life-threatening Form Of Leukemia

🕔12/9/2008 8:47:00 AM 3444

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current And Pipeline Therapies

🕔12/4/2008 5:17:00 PM 4205

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Sandoz Receives Positive EU Opinion For Biosimilar Filgrastim

🕔11/21/2008 10:51:00 PM 1477

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Rasilez HCT® Receives Recommendation For European Approval As A Single-pill Combination To Treat High Blood Pressure

🕔11/21/2008 10:47:00 PM 1290

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Novartis Highlights Innovative Approach To Drug Discovery With Dynamic Advance In Exploratory Pipeline

🕔11/19/2008 4:13:50 PM 1758

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (VTX:NOVN) Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril In Patients 65 And Older

🕔11/12/2008 2:33:00 AM 1223

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (SWF:NOVN) Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure

🕔10/29/2008 5:19:00 PM 1226

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Novartis International AG (SWF:NOVN) ACZ885 Phase III Data Show Rapid, Sustained Clinical Remission In Children And Adults Suffering From A Group Of Rare, Potentially Life-threatening Autoinflammatory Diseases

🕔10/27/2008 5:17:00 PM 1228

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel
###

47,958 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 63) (letzten 30 Tagen: 285) (seit Veröffentlichung: 16521) 

Company Data

    Principal Sector
  • Gesundheit & Pharm 
  • Principal Industry
  • Pharmaceutical 
  • Homepage
  • www.novartis.de